LUNGevity is proud to be guided and inspired by our Health Equity Council, made up of leaders from a variety of lived experiences, racial/ethnic identities, gender identities, geographies, organizational settings, areas of professional expertise, and career stages. Together, we are committed to ensuring that all people diagnosed with lung cancer have the same opportunities for best-case outcomes and access to trusted resources, irrespective of their geographic location, socioeconomic status, race, ethnicity, age, or marginalization in society.  

Members of the Health Equity Council will meet annually to optimize the impact of the Foundation’s national  community-network strategy focused on health literacy, lung cancer screening, biomarker testing, and inclusion in clinical trials.

Health Equity Council Members

Stacey Alphas

Stacey Alphas

Bristol Myers Squibb
Associate Director, Clinical Trial Engagement Strategy

Stacey Alphas is a passionate patient advocate and is dedicated to understanding the burden on patients as they navigate through their disease and treatment journey.


Francesca Angeletti

Francesca Angeletti

Amgen Oncology
Director of US and Global Advocacy Relations

In this role, Francesca has responsibilities for designing corporate strategies and driving their implementation, including Amgen’s outreach to patient and provider associations.


LeeAnn Bailey, MBBS, PhD, MS

LeeAnn Bailey, MBBS, PhD, MS

National Cancer Institute
Chief of the Integrated Networks Branch, CRCHD

Dr. Bailey develops, and assesses strategies for enhancing the integration and dissemination of diversity training, women’s health, and sexual and gender minority efforts within and across NCI, as well as within the scientific community and underserved communities through NCI-supported networks.


Upal Basu Roy, PhD, MPH

Upal Basu Roy, PhD, MPH

LUNGevity Foundation
Executive Director of Research

As a patient research advocate, he works with national organizations on policy initiatives to make clinical trials more streamlined and patient-centric. He also serves on several advisory boards both in the for-profit and non-profit sector.


Carla Berg, PhD, MBA, LP

Carla Berg, PhD, MBA, LP

George Washington Cancer Center
Associate Center Director for Population Sciences and Policy
Milken Institute School of Public Health
Professor, Department of Prevention and Community Health

Dr. Berg’s research primary focuses on socio-contextual factors related to substance use, particularly tobacco and marijuana, ranging from macro-level factors such as policy and marketing to interpersonal and individual factors.


Josh Bergren

Josh Bergren

Pfizer Oncology
Director of Patient Advocacy and Professional Relations

Josh works to build partnerships with external patient advocacy groups and professional societies in order to execute breakthrough collaborations that help solve for the complexity of a cancer diagnosis.


Lynette Bonar, RN, MBA, FACHE

Lynette Bonar, RN, MBA, FACHE

Tuba City Regional Health Care Corporation
Chief Executive Officer

Lynette Bonar established the first and only cancer clinic on any American Indian reservation and she is the first woman to be in charge of a Navajo health care system.


Rickie Brawer, PhD, MPH, MCHES

Rickie Brawer, PhD, MPH, MCHES

Jefferson Enterprise
Vice President and Chief Community Engagement Officer
Thomas Jefferson University Hospital Center for Urban Health
Co-Director
Sidney Kimmel Medical College
Assistant Professor, Department of Family and Community Medicine

Dr. Brawer is commitment to improve the health of the community through community health assessment and planning, health promotion and education, advocacy and research.


Romnee Clark, MD

Romnee Clark, MD

Eli Lilly
Medical Fellow

Dr. Clark’s passion is to engage medically underserved cancer patients.


Lisa Cruz, MPA

Takeda 
Lead, Global and US Lung Cancer, Patient Advocacy and Engagement 

Lisa is passionate about helping to ensure all people – regardless of their social or economic – have the opportunity to attain their optimal health. 


Narjust Duma, MD

Narjust Duma, MD

University of Wisconsin School of Medicine and Public Health
Assistant Professor, Division of Hematology, Medical Oncology, and Palliative Care

Dr. Duma’s clinical interests include medical oncology with emphasis on thoracic cancer, including small cell and non-small cell lung cancer, thymic malignancies and mesothelioma.


Cherie Erkmen, MD

Cherie P. Erkmen, MD

Temple University Health Systems
Professor and Director, Temple University Lung Cancer Screening Program

Dr. Erkmen specializes in robotic techniques to deliver the highest quality of care thoracic surgery patients. She is a devoted educator and the founding Program Director of the ACGME-Accredited Thoracic Surgery Fellowship at Temple.


Andrea Ferris, MBA

Andrea Ferris, MBA

LUNGevity Foundation
President and CEO
Member, Board of Directors

Andrea is responsible for setting and executing the strategic direction of LUNGevity Foundation organization and its science programs.


Marvella Ford, PhD

Marvella Ford, PhD

Medical University of South Carolina
Hollings Cancer Center

Associate Professor for Bioinformatics and Epidemiology
Associate Director of Cancer Disparities

Dr. Ford’s research focuses on personal and socioeconomic factors impacting cancer screening and detection among underserved and minority populations such as race, gender, and education.


Marianne Gandee

Marianne Gandee

Pfizer Oncology
Senior Director of Advocacy and Professional Relations

Marianne has a track record of building strong relationships with external and internal stakeholders and leads her team in working with thought-leaders on a wide-range of oncology-focused advocacy and education initiatives.


Sara Green

Sara Green

AstraZeneca
Director of Advocacy and Alliance

Sara’s deep experience includes patient and professional engagement, healthcare education and policy issues at the national and state level. She is interested in reducing disparities to care.


Patti Jewell, MPA

Patti Jewell, MPA

Pfizer Oncology
Senior Director, Patient Advocacy

Patti Jewell is Senior Director, Patient Advocacy, in Pfizer’s Chief Patient Office, focusing on collaborating with patient advocacy organizations across therapeutic areas on health equity, health literacy and patient centricity initiatives in the US.


Colette McCoy

Colette McCoy

AstraZeneca
US Lead, Lung Ambition Alliance

Colette has 20+ years of pharmaceutical industry experience across multiple roles, including her most recent experience supporting innovative partnerships to address gaps in care with major oncology practices and institutions in southeastern parts of the US.


Devon McGoldrick, MPH, CCPH

Devon McGoldrick, MPH, CCPH

Eli Lilly
Advisor, Advocacy and Professional Relations

Devon is committed to improving experiences and outcomes for all people affected by a cancer diagnosis.


Ellen Miller Sonet, MBA, JD

Ellen Miller-Sonet, MBA, JD

CancerCare
Chief Strategy and Alliance Officer

Ellen Miller-Sonet leads the strategic initiatives and national policy agenda for CancerCare, the leading national organization providing free, professional support services and information to help people manage the emotional, practical, and financial challenges of cancer.


Sarah Neils

Sarah Neils

AstraZeneca
Manager, US Oncology Policy

Sarah has led the multicultural lung cancer initiative, “It’s Okay to Ask”, seeking to empower patients of Asian descent and their and caregivers to proactively seek out disease and treatment information and raise awareness of advances in lung cancer care.


Jude Ngang, PharmD

Amgen
Director, Diversity and Representation in Clinical Research

Jude Ngang is Director, Diversity and Representation in Clinical Research at Amgen. 


Raymond Osarogiagbon, MD

Raymond Osarogiagbon, MD

Baptist Cancer Center
Director of the Multidisciplinary Thoracic Oncology Program
Vanderbilt University
Research Professor
Vanderbilt Ingram Cancer Center
Research Member

Dr. Osarogiagbon is interested on improving population-based systems of care, improving the accuracy of cancer staging and evaluating the biologic drivers of outcome differences in potentially curable lung cancer.


Kemi Osundina, PharmD, MS

Kemi Osundina, PharmD, MS

Bristol Myers Squibb
Associate Director of Health Equity and New Partnerships

Dr. Osundina leads patient advocacy efforts supporting Lung, Mesothelioma, Head & Neck, and Glioblastoma cancers. She is also leading the US Advocacy Health Equity Strategy to ensure that every BMS advocacy initiative is considered through a Health Equity lens.


Manali I Patel MD MPH MS

Manali I. Patel MD, MPH, MS

Stanford University School of Medicine 
Assistant Professor
VA Palo Alto Health Care System
Staff Oncologist

Dr. Manali I. Patel is a medical thoracic oncologist and health services researcher at the Stanford University School of Medicine and the Veterans Affairs Palo Alto Health Care System. 


Bruce Rapkin, PhD

Bruce Rapkin, PhD

Albert Einstein College of Medicine
Professor, Department of Epidemiology and Population Health
Professor, Department of Family and Social Medicine

Dr. Rapkin’s area of research focuses on building community-academic partnerships that can reduce barriers and improve standard of care.


Jeanne Regnante

LUNGevity Foundation
Chief Health Equity and Diversity Officer
Chair of LUNGevity Foundation’s Health Equity Council

Jeanne’s primary objective is to secure the engagement and insights of vulnerable lung cancer communities by working with trusted community-based organizations and multiple health care stakeholders to achieve health equity and equalize disparities for all.


Fatima Scipione

Fatima Scipione

Takeda Oncology
Head of Oncology Patient Advocacy & Engagement

In Fatima’s role as Head of Oncology Patient Advocacy & Engagement, she leads a global team responsible for engaging with the patient community to bring better medicines  to people with cancer. Fatima is passionate about elevating the patient voice on a global scale.


NFN Scout, MA, PhD

NFN Scout, MA, PhD

National LGBT Cancer Network
Executive Director

Scout leads a team at National LGBT Cancer Network that focus on building tools and sharing strategies across state departments of health.


Nichelle Stigger

Nichelle Stigger

Patient Advocate
Member, LUNGevity Board of Directors

Nichelle is a lung cancer survivor-advocate with a goal to speak as an African American woman experiencing cancer, the equitable treatment of people of color in cancer, and diminishing the stigma of lung cancer.


Jasmin Tiro, PhD

Jasmin Tiro, PhD

UT Southwestern Medical Center
Simmons Comprehensive Cancer Center

Associate Professor, Division of Behavioral and Communication Sciences, Department of Population and Data Sciences
Associate Director, Community Outreach, Engagement, and Equity

Dr. Tiro is committed toward disseminating behavioral interventions aimed at ending cancer disparities. Her research interests include cancer health disparities, cancer screening, the HPV vaccine, and mixed methods research.


Karriem S. Watson, DHSC, MS, MPH

Karriem S. Watson, DHSC, MS, MPH

Mile Square Health Center
Associate Executive Director
University of Illinois Cancer Center at UIC
Associate Director of Community Outreach and Engagement
UIC School of Public Health
Research Assistant Professor

Dr. Watson’s research is focused on cancer prevention and control and mitigating the impact of social determinants of health on chronic conditions such as diabetes and hypertension.


Katherine Winfree, PhD, MS, MPH

Katherine Winfree, PhD, MS, MPH

Eli Lilly
Principal Research Scientist

Katherine Winfree is a Principal Research Scientist in Global Patient Outcomes and Real-World Evidence at Eli Lilly and Company.


Karen Winkfield, MD, PhD

Karen Winkfield, MD, PhD

Meharry-Vanderbilt Alliance
Executive Director

Dr. Winkfield is a national expert in community engagement with research focused on the design and implementation of programming to reduce sociocultural and economic barriers that contribute to disparate health outcomes for racial and ethnic minorities and underserved populations.


Robert Winn, MD

Robert Winn, MD

VCU Massey Cancer Center
Director

Dr. Winn is committed to developing methods to eliminate health disparities by empowering underserved patient populations, improve health-care deliver, and ensuring equal access to cutting-edge medical treatments.